[HTML][HTML] COVID-19 vaccine booster: to boost or not to boost
Developing safe and effective vaccines against severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) at a breakneck speed has been an exceptional human …
coronavirus 2 (SARS-CoV-2) at a breakneck speed has been an exceptional human …
COVID‐19 vaccinations: the unknowns, challenges, and hopes
The entire world has been suffering from the coronavirus disease 2019 (COVID‐19)
pandemic since March 11, 2020. More than a year later, the COVID‐19 vaccination brought …
pandemic since March 11, 2020. More than a year later, the COVID‐19 vaccination brought …
COVID-19 vaccines: concerns beyond protective efficacy and safety
Introduction Several vaccine candidates have been developed using different platforms,
including nucleic acids (DNA and RNA), viral vectors (replicating and non-replicating), virus …
including nucleic acids (DNA and RNA), viral vectors (replicating and non-replicating), virus …
COVID-19 and vaccination: myths vs science
Introduction Several vaccines against severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) have been developed since the inception of the coronavirus disease 2019 …
(SARS-CoV-2) have been developed since the inception of the coronavirus disease 2019 …
[HTML][HTML] COVID-19 vaccine boosters: the good, the bad, and the ugly
Pursuing vaccinations against COVID-19 brings hope to limit the spread of SARS-CoV-2
and remains the most rational decision under pandemic conditions. However, it does not …
and remains the most rational decision under pandemic conditions. However, it does not …
[HTML][HTML] SARS-CoV-2 vaccines: status report
F Amanat, F Krammer - Immunity, 2020 - cell.com
SARS-CoV-2, the causal agent of COVID-19, first emerged in late 2019 in China. It has since
infected more than 870,000 individuals and caused more than 43,000 deaths globally. Here …
infected more than 870,000 individuals and caused more than 43,000 deaths globally. Here …
Landscape and progress of global COVID-19 vaccine development
HY Huang, SH Wang, Y Tang, W Sheng… - Human Vaccines & …, 2021 - Taylor & Francis
The emergence of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has
affected billions of lives globally, and the world hopes to end this epidemic by effective …
affected billions of lives globally, and the world hopes to end this epidemic by effective …
[HTML][HTML] The 2020 pandemic: current SARS-CoV-2 vaccine development
SO Alturki, SO Alturki, J Connors, G Cusimano… - Frontiers in …, 2020 - frontiersin.org
Coronaviruses are enveloped viruses with a positive-sense single-stranded RNA genome
infecting animals and humans. Coronaviruses have been described more than 70 years ago …
infecting animals and humans. Coronaviruses have been described more than 70 years ago …
A systematic review of coronavirus disease 2019 vaccine efficacy and effectiveness against severe acute respiratory syndrome coronavirus 2 infection and disease
Billions of doses of coronavirus disease 2019 (COVID-19) vaccines have been administered
globally, dramatically reducing severe acute respiratory syndrome coronavirus 2 (SARS …
globally, dramatically reducing severe acute respiratory syndrome coronavirus 2 (SARS …
COVID-19 vaccine effectiveness among immunocompromised populations: a targeted literature review of real-world studies
M Di Fusco, J Lin, S Vaghela… - Expert Review of …, 2022 - Taylor & Francis
ABSTRACT Introduction From July through October of 2021, several countries issued
recommendations for increased COVID-19 vaccine protection for individuals with one or …
recommendations for increased COVID-19 vaccine protection for individuals with one or …